BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Adams Respiratory Therapeutics Takes Ownership Of OTC & Rx Medications Of Humibid


10/19/2005 5:12:44 PM

CHESTER, N.J., Feb. 15 /PRNewswire/ -- Adams Respiratory Therapeutics ("Adams") announced today a business transaction involving the AlleRx(TM) & Humibid(TM) families of products. Effective today, Adams will transfer the AlleRx(TM) family of prescription respiratory medications to Cornerstone BioPharma, which will in turn transfer the Humibid(TM) trademark to Adams. Humibid(TM) is currently marketed as an OTC product under the names Humibid(TM) e and Humibid(TM) CS.

The Humibid(TM) trademark will complement Mucinex(R), the company's flagship brand of OTC respiratory medications.

"The Humibid(TM) brand is highly regarded among the professional healthcare community and was prescribed approximately 2 million times during calendar year 2004," said Michael J. Valentino, President and CEO of Adams. Valentino continued, "We intend to leverage the brand equity and prescription heritage that Humibid(TM) enjoys in the professional community as we add to our portfolio of products."

About Adams Respiratory Therapeutics

Based in Chester, New Jersey, Adams Respiratory Therapeutics develops, markets and sells prescription and non-prescription pharmaceuticals for the treatment of respiratory disorders and diseases. More information can be found on the company's Web site at http://www.adamsrt.com/.

Adams Respiratory Therapeutics

CONTACT: Kajal Jhaveri of Ruder Finn, +1-212-593-5864,jhaverik@ruderfinn.com, for Adams Respiratory Therapeutics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES